Skip to content
Screener

AbCellera Biologics Inc. ABCL Prepaid & Other Current

Prepaid & Other Current at other companies

Schrodinger logo
SchrodingerSDGR
$10.55M-29.4%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$54.1M+416%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$8.68M
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$17.36M-33.8%
Absci Corporation logo
Absci CorporationABSI
$6.27M+38.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$7.61M+300%

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$2.12B+57.4%
Enterprise value$2.11B+53.8%
P/S32×-8.9×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001703057-26-000046
Line itemDecember 31, 2025June 30, 2026
Total cash, cash equivalents, and marketable securities533,826540,104
Accounts and accrued receivable58,29318,597
Restricted cash25,00025,000
Other current assets111,11395,529
Total current assets728,232679,230
Long-term assets:
Property and equipment, net428,003416,677
Intangible assets, net38,38136,530

Item 1. Financial Statements (Unaudited)

FAQ

What is AbCellera Biologics Inc.'s prepaid & other current?
AbCellera Biologics Inc. (ABCL) reported prepaid & other current of $95.53M in Q2 2026.
How has AbCellera Biologics Inc.'s prepaid & other current changed year-over-year?
AbCellera Biologics Inc.'s prepaid & other current decreased by 18.2% year-over-year, from $116.76M to $95.53M.
What is the long-term trend for AbCellera Biologics Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s prepaid & other current has grown at a 79.5% compound annual growth rate (CAGR), from $5.97M to $111.11M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about AbCellera Biologics Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude